Given PERK’s involvement in the onset of diseases like cancer, diabetes, and neurodegenerative disorders, it’s tempting to postulate that the TRIM29-mediated SUMOylation of PERK might be a key regulator in their respective pathogenesis. This evidence concerns the gene TRIM29 and cancer.